{"url":"https://lda.senate.gov/api/v1/filings/15219dd8-fb22-4e23-a99e-c91c3f3dc1d0/","filing_uuid":"15219dd8-fb22-4e23-a99e-c91c3f3dc1d0","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2013,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/15219dd8-fb22-4e23-a99e-c91c3f3dc1d0/print/","filing_document_content_type":"text/html","income":"100000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"David M. McIntosh, Partner","dt_posted":"2013-07-19T17:41:11.053000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1999 K Street, NW","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20006","registrant":{"id":24123,"url":"https://lda.senate.gov/api/v1/registrants/24123/","house_registrant_id":31349,"name":"MAYER BROWN LLP","description":"Law firm","address_1":"1999 K Street NW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MICKEY LEIBNER","contact_telephone":"+1 202-263-3711","dt_updated":"2026-01-30T11:06:00.167379-05:00"},"client":{"id":131427,"url":"https://lda.senate.gov/api/v1/clients/131427/","client_id":1005270,"name":"QIAGEN, INC.","general_description":"Biotechnology company","client_government_entity":false,"client_self_select":false,"state":"MD","state_display":"Maryland","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2013-04-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"CMS reimbursement rates for molecular diagnostic tests.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":41122,"prefix":null,"prefix_display":null,"first_name":"TIFFANY","nickname":null,"middle_name":"L","last_name":"SMITH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}